A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Stopped early · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate 3 test formulations relative to a reference formulation.

Key facts

Study ID

NCT01634789

Run by

Pfizer

People needed

2

Starts

2012-08-01

Expected to finish

2012-11-01

Last updated by the study team

2013-01-18

Who can join

Age: 45 and older, up to 64. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Generally healthy postmenopausal women
• Body mass index (BMI) in the range of 18.0 to 35.0 kg/m2 and body weight >= 50 kg

You may not qualify if…

• Pregnant or nursing females; females of childbearing potential

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.